Close

Aeterna Zentaris (AEZS) Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing

Go back to Aeterna Zentaris (AEZS) Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing

Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing

July 29, 2021 8:05 AM EDT

CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (Aeterna or the Company), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that on July 28, 2021, the Company received notice from the Listing Qualifications Department (the Staff) of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, based upon a closing bid price of less than $1.00 per share for the Companys common stock for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq... More